'Hematological disorders' presentation slideshows

Hematological disorders - PowerPoint PPT Presentation

IGRAs for Diagnosis of Tuberculosis: 2010 Update

IGRAs for Diagnosis of Tuberculosis: 2010 Update

IGRAs for Diagnosis of Tuberculosis: 2010 Update. Nira Pollock, M.D., Ph.D. Division of Infectious Diseases Beth Israel Deaconess Medical Center Boston, MA May 1, 2010. Problems with the PPD. False positives Recent BCG vaccine non-TB mycobacteria (NTM) False negatives

★ ★ ★ ★ ★

672 views • 54 slides
Transient Ischaemic Attacks in East Lancashire 21 November 2012

Transient Ischaemic Attacks in East Lancashire 21 November 2012

Transient Ischaemic Attacks in East Lancashire 21 November 2012 . Dr Arun Kumar Singh Consultant Physician East Lancashire Hospital NHS Trust. Transient ischaemic attack (TIA)

★ ★ ★ ★ ★

547 views • 39 slides
Anemia

Anemia

Anemia . Anemia . Hb being below the referance range for the age and sex The normal ranges vary with age -neonate < 14g/dl -1-12mths < 10mg/dl -1-12y< 11 g/dl. Causes of anemia can be from. Reduced cell production Increased destruction Blood loss. Clinical Features:-.

★ ★ ★ ★ ★

412 views • 14 slides
PDGF Receptor Beta & Chronic Myelenomonocitic Leukemia

PDGF Receptor Beta & Chronic Myelenomonocitic Leukemia

PDGF Receptor Beta & Chronic Myelenomonocitic Leukemia. PDGFR-B is a receptor tyrosine kinase and is distinct from PDGFR-A. PDGF signaling activates a number of key pathways in the cell. PDGFRB null mutants showed abnormal kidney development and hematological disorders.

★ ★ ★ ★ ★

97 views • 9 slides
Hemophilia A Pipeline Review, Industry Analysis Report 2018

Hemophilia A Pipeline Review, Industry Analysis Report 2018

Hemophilia A Pipeline Review is an X-linked, recessive disorder caused by deficiency of functional plasma clotting factor VIII (FVIII), which may be inherited or arise from spontaneous mutation. https://www.aarkstore.com/pharmaceuticals-healthcare/987025/hemophilia-a-pipeline-review-h2

★ ★ ★ ★ ★

90 views • 8 slides
Hypereosinophilic Syndrome Market Future Outlook, Market Growth Analysis-Ken Research

Hypereosinophilic Syndrome Market Future Outlook, Market Growth Analysis-Ken Research

The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (? 1500 eosinophils/mm) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out. For more information on the research report, visit https://www.kenresearch.com/healthcare/pharmaceuticals/hypereosinophilic-syndrome-pipeline-review-h1-2018/149564-91.html

★ ★ ★ ★ ★

41 views • 2 slides

View Hematological disorders PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Hematological disorders PowerPoint presentations. You can view or download Hematological disorders presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.